Publications

• Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients (with Rosanna Smart, Rosalie Liccardo Pacula, Evan D. Peet, Rahi Abouk, and Corey S. Davis), forthcoming at Journal of Health Economics.

• Ransomware Attacks, ED Visits and Inpatient Admissions in Targeted and Nearby Hospitals (with Rahi Abouk), JAMA: doi:10.1001/jama.2024.7752, 2024.  

• Price Sensitivity and Information Barriers to the Take-up of Naloxone (with Mireille Jacobson), forthcoming at American Economic Journal: Economic Policy.

• Opioid Prescribing Patterns After Imposition of Setting-Specific Limits on Prescription Duration (with Lindsay D. Allen, Robin A. Pollini, and Richard Vaglienti), JAMA Health Forum, 5(1): e234731, 2024.

• Growth in Suicide Rates Among Children During the Illicit Opioid Crisis, Demography, 11077660, 2023.

• Educational Attainment and US Drug Overdose Deaths, JAMA Health Forum, 4(10): e233274, 2023.

• The Value of Working Conditions in the United States and Implications for the Structure of Wages (with Nicole Maestas, Kathleen J. Mullen, Till von Wachter, and Jeffrey B. Wenger),  American Economic Review, 113(7): 2007-2047, 2023.

• A Randomized Trial of Letters to Encourage Prescription Drug Monitoring Program Use and Safe Opioid Prescribing (with Adam Sacarny, Tatyana Avilova, Ian Williamson, Weston Merrick, and Mireille Jacobson), Health Affairs, 42(1): 140-149, 2023.

• The Effect of Population Aging on Economic Growth, the Labor Force and Productivity (with Nicole Maestas and Kathleen J. Mullen), American Economic Journal: Macroeconomics, 15(2): 306-32, 2023.

• Pain Management and Work Capacity: Evidence from Workers' Compensation and Marijuana Legalization (with Rahi Abouk, Keshar Ghimire, and Johanna Catherine Maclean), Journal of Policy Analysis and Management: 42(3): 737-770, 2023.   

• Understanding the Rise in Overdose Deaths Involving Opioids and Non-Opioid Prescription Drugs in the United States (with Evan D. Peet and Rosalie Liccardo Pacula), accepted at International Journal of Drug Policy, 2023.   

• Relationship of POLST to Hospitalization and ICU Care Among Nursing Home Residents in California (with David S. Zingmond, Lee A. Jennings, Jose J. Escarce, Li-Jung Liang, Punam Parikh, and Neil S. Wenger), Journal of General Internal Medicine, https://doi.org/10.1007/s11606-023-08357-3, 2023.

• Trends in Overdose Deaths involving Gabapentinoids and Z-drugs in the United States (with Kanaka Shetty and Evan D. Peet), Drug and Alcohol Dependence, 249: 109952, 2023.

• Changes over Time in POLST use and content by race and ethnicity among California nursing home residents (with David S. Zingmond, Lee A. Jennings, Li-Jung Liang, Jose J. Escarce, Punam Parikh, and Neil S. Wenger), Journal of the American Geriatrics Society, 2023.

• Do Temporary Workers Experience Additional Employment and Earnings Risk After Workplace Injuries? (with Nicholas Broten and Michael Dworsky), Journal of Public Economics, 209: 104628, 2022.

• Origins of the Opioid Crisis and Its Enduring Impacts (with Abby Alpert, Bill Evans, Ethan Lieber), The Quarterly Journal of Economics, 137(2): 1139-1179, 2022.

• Synthetic Control Estimation Beyond Comparative Case Studies: Does the Minimum Wage Reduce Employment?, Journal of Business & Economic Statistics, 40(3): 1302-1314, 2022.

• Trends in the Concurrent Prescription of Opioids and Gabapentin in the US, 2006 to 2018 (with Evan D. Peet, Beth Dana, Flora Yaou Sheng, Kanaka Shetty, and Bradley D. Stein), JAMA Internal Medicine, 183(2): 162-164, 2022.

• Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018 (with Evan D. Peet and Rosalie L. Pacula), JAMA Health Forum, 3(8): e222663, 2022.

• Analysis of Substance Use Disorder Treatment Admissions in the US by Sex and Race and Ethnicity Before and During the COVID-19 Pandemic (with Jonathan H. Cantor, Christopher M. Whaley, and Bradley D. Stein), JAMA Network Open, 5(9): e2232795, 2022.

• Quantile Regression with Nonadditive Fixed Effects, Empirical Economics, 63: 2675-2691, 2022. 

• Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic (with Annie Y. Chen and Bradley D. Stein), JAMA Network Open, 5(7): e2223708, 2022.

• Care preferences in physician orders for life sustaining treatment in California nursing homes (with Lee A. Jennings, Neil S. Wenger, Li-Jung Liang, Punam Parikh, Jose J. Escarce, and David Zingmond), Journal of the American Geriatrics Society, 2022.

• Population-based estimates of geographic accessibility of medication for opioid use disorder by substance abuse disorder treatment facilities from 2014 to 2020 (with Jonathan Cantor,  Aaron Kofner, and Bradley D. Stein), Drug and Alcohol Dependence, 229: 109107, 2021.

• Moving beyond the classic difference-in-differences models: a simulation study comparing statistical methods for estimating effectiveness of state-level policies (with Beth Ann Griffin, Megan S. Schuler, Elizabeth A. Stuart, Elizabeth McNeer, Rosanna Smart, Bradley Stein, Terry Schell, and Rosalie Liccardo Pacula), BMC Medical Research Methodology, 21(1): 1-19, 2021.

• Disentangling Moral Hazard and Adverse Selection in Private Health Insurance (with Dana Goldman), Journal of Econometrics, 222(1): 141-160, 2021.

• Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?  (with Sujeong Park), Journal of Health Economics, 76: 102430, 2021.

• Can Electronic Prescribing Mandates Reduce Opioid-Related Overdoses? (with Rahi Abouk), Economics and Human Biology, 42: 10100, 2021.

• The Evolving Consequences of OxyContin Reformulation on Drug Overdoses (with Rosalie Liccardo Pacula), American Journal of Health Economics, 7(1): 41-67, 2021.

• Individual and Community Factors Associated with Naloxone Co-Prescribing Among Long-Term Patients: A Retrospective Analysis (with Bradley D. Stein, Rosanna Smart, Christopher M. Jones, Flora Sheng, and Mark Sorbero), Journal of General Internal Medicine, 2021. 

• POLST Completion and Continuity in California Nursing Homes (with David S. Zingmond, Lee A. Jennings, Jose J. Escarce, Li-Jung Liang, Punam Parikh, and Neil S. Wenger).  Journal of the American Geriatrics Society, 2021.

• Quantile Treatment Effects in the Presence of Covariates, Review of Economics and Statistics, 102(5): 994-1005, 2020.

• Does Labor Supply Respond to Transitory Income?  Evidence from the Economic Stimulus Payments of 2008, Journal of Labor Economics, 38(1): 1-38, 2020.

• When is a Match Sufficient?  A Score-based Balance Metric for the Synthetic Control Method (with Layla Parast, Priscillia Hunt, and Beth Ann Griffin), Journal of Causal Inference, 8(1): 209-228, 2020.

• The State of the Science in Opioid Policy Research (with Megan S. Schuler, Sara E. Heins, Rosanna Smart, Beth Ann Griffin, Elizabeth A. Stuart, Bryce Pardo, Sierra Smucker, Stephen W. Patrick, Rosalie Liccardo Pacula, Bradley D. Stein), Drug and Alcohol Dependence, 214(1): 108137, 2020.  

• How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D (with Rosalie Liccardo Pacula and Erin A. Taylor), Journal of Health Economics, 71: 102286, 2020.

• Estimating Intensive and Extensive Tax Responsiveness (with Abby Alpert), Economic Inquiry, 58(4): 1855-1873, 2020.

• The Distortionary Effects of the Health Insurance Tax Exclusion, American Journal of Health Economics, 5(4): 428-464, 2019.

• Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose (with Rahi Abouk and Rosalie Liccardo Pacula), JAMA Internal Medicine, 179(6): 805-811, 2019.

• A Transitioning Epidemic: How the Opioid Crisis is Driving the Rise in Hepatitis C (with Abby Alpert and Rosalie Liccardo Pacula), Health Affairs, 38(2): 287-294, 2019.

• Medical Care Spending and Labor Market Outcomes: Evidence from Workers' Compensation Reforms (with Seth Seabury), American Economic Review, 108(10):2995-3027, 2018.       

• Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids (with Abby Alpert and Rosalie Liccardo Pacula), American Economic Journal: Economic Policy, 10(4):1-35, 2018.

• Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (with Rosalie Liccardo Pacula and Mireille Jacobson), Journal of Health Economics, 58:29-41, 2018.

• A Supply-Side Perspective on the Opioid Crisis (with Rosalie Liccardo Pacula), Journal of Policy Analysis and Management, 37(2):438-446, 2018.

• The Effect of the 2009 Influenza Pandemic on Absence from Work (with Fabian Duarte, Srikanth Kadiyala, and Samuel H. Masters), Health Economics, 26(12): 1682-1695, 2017.

• Assessing the Effects of Medical Marijuana Laws on Marijuana Use: the Devil is in the Details (with Rosalie Liccardo Pacula, Paul Heaton, and Eric Sevigny), Journal of Policy Analysis and Management, 34(1): 7-31, 2015.

• The Exporter Productivity Premium along the Productivity Distribution: Evidence from Quantile Regression with Nonadditive Firm Fixed Effects (with Joachim Wagner), Review of World Economics, 150(4): 763-85, 2014.

• Income Taxes, Compensating Differentials, and Occupational Choice: How Taxes Distort the Wage-Amenity Decision (with Hui Shan), American Economic Journal: Economic Policy, 4(1): 224-47, 2012.

• Compensating Differentials and Income Taxes: Are the Wages of Dangerous Jobs More Responsive to Income Tax Changes than the Wages of Safe Jobs? Journal of Human Resources, 47(4): 1023-54, 2012. 

Book Chapters:

David Powell and Rosalie Liccardo Pacula (2017).  “Prescription Opiates and Opioid Abuse: Regulatory Efforts to Limit Diversion from Medical Markets to Black Markets in the United States” in Dual Markets: Comparative Approaches for Regulation, edited by E. Savona and M.A.R. Kleiman.  New York: Springer.